References
- Aldred S, Grant M M. The use of proteomics for the assessment of clinical samples in research. Clin Biochem 2004; 37: 943–952, [PUBMED], [INFOTRIEVE], [CSA]
- Benveniste E N, Benos D J. TNF-alpha- and IFN-gamma-mediated signal transduction pathways: effects on glial cell gene expression and function. Faseb J 1995; 9: 1577–1584, [PUBMED], [INFOTRIEVE], [CSA]
- Brew B J, Bhalla R B. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol 1990; 28: 556–560, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Brouwers P, Heyes M P. Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J Infect Dis 1993; 168: 1380–1386, [PUBMED], [INFOTRIEVE], [CSA]
- Ciborowski P, Enose Y. Diminished matrix metalloproteinase 9 secretion in human immunodeficiency virus-infected mononuclear phagocytes: modulation of innate immunity and implications for neurological disease. J Neuroimmunol 2004; 157: 11–16, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ferguson P L, Smith R D. Proteome analysis by mass spectrometry. Annu Rev Biophys Biomol Struct 2003; 32: 399–424, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- LeBlanc J, Letendre S. Dementia-associated protein biomarkers found in cerebrospinal fluid (CDF) by surface enhanced desorption and ionization (SELDI) proteinChip analysis (Abstract #611). 8th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, 2001
- Luo X, Carlson K A. Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 2003; 60: 1931–1937, [PUBMED], [INFOTRIEVE], [CSA]
- McArthur J C, Nance-Sproson T E. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. Neurology 1992; 42: 1707–1712, [PUBMED], [INFOTRIEVE], [CSA]
- Persidsky Y, Gendelman H E. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J Leukoc Biol 2003; 74: 691–701, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pocernich C B, Boyd-Kimball D. Proteomics analysis of human astrocytes expressing the HIV protein Tat. Brain Res Mol Brain Res 2005a; 133: 307–316, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pocernich C B, Fai Poon H. Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat. Brain Res Mol Brain Res 2005b; 133: 299–306, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Towfighi A, Skolasky R L. CSF soluble Fas correlates with the severity of HIV-associated dementia. Neurology 2004; 62: 654–656, [PUBMED], [INFOTRIEVE], [CSA]
- Wojna V, Carlson K A. Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: a case study. J NeuroVirol 2004; 10: 74–81, Suppl 1[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]